News | June 05, 2015

Medtronic Announces CE Mark and European Launch of Euphora Semicompliant Coronary Balloon

Enhanced delivery system facilitates improved stent access to tight lesions

Medtronic, Euphora SC balloon, CE Mark, Europe, Richard Edwards

June 5, 2015 - Medtronic announced the launch of the Euphora semicompliant balloon dilatation catheter in countries that recognize the CE (Conformité Européene) mark in February. The first patient case with the Euphora was performed in the same month by Richard Edwards, M.D., consultant cardiologist at the Freeman Hospital in Newcastle, United Kingdom.

"After performing the first patient case with Euphora, it is the most deliverable balloon catheter I have used," said Edwards. "The exceptionally low crossing profile and pushability make it ideal for complex situations and workhorse lesions alike."

Pre-dilatation with a semicompliant balloon helps physicians determine lesion characteristics, stent selection and facilitates stent access to the lesions - a crucial step for patients with complex lesions.

The Euphora semicompliant balloon catheter features several design advancements including:

  • Delivery system with PowerTrac technology to provide superior deliverability (compared to major competitors) through tight lesions. The delivery system was first introduced with the Medtronic NC Euphora noncompliant balloon dilatation catheter last year and is also featured with the Medtronic Resolute Onyx drug-eluting stent; ­­­
  • Ultra-slim balloon material, a tapered proprietary inner shaft design and an optimized mini-wrap to reduce the wall thickness of the balloon and contribute to the extremely low crossing profile; 
  • Significantly improved insertion and retraction force to enhance navigation to lesion sites when using the Kissing Balloon Technique, a method for treating bifurcated lesions;
  • Environmentally friendly packaging, a reduced box size that has a smaller footprint on congested shelves and improved product labeling for fast readability to improve efficiency in the cath lab; and
  • Enhanced crossability may create economic value to the cath labs through the use of a single balloon prepping a lesion, thus reducing the need for the "step up" technique which requires several balloons of different size to first cross the tight lesions and then gradually expand sizing before treating with a stent.

The device launched in the United States in May.

For more information:

Related Content

Gore Molding & Occlusion Balloon for Endovascular Aortic Repair Receives FDA Approval
Technology | Balloon Catheter | August 23, 2018
W. L. Gore & Associates Inc. (Gore) announced U.S. Food and Drug Administration (FDA) 510(k) clearance for the Gore...
Cardiovascular Systems Inc. and OrbusNeich Announce FDA Clearance  of Sapphire II Pro 1mm Coronary Balloon
Technology | Balloon Catheter | March 21, 2018
Cardiovascular Systems Inc. (CSI) recently announced that the U.S. Food and Drug Administration (FDA) has granted 510(k...
Cardiovascular Systems Expands Product Portfolio for Peripheral and Coronary Interventions
News | Balloon Catheter | January 24, 2018
Cardiovascular Systems Inc. recently announced two new partnerships broadening the company’s product portfolio. CSI is...
Abbott recalls its NC Balloon catheters
News | Balloon Catheter | May 22, 2017
May 22, 2017 — Abbott Vascular has initiated a voluntary recall of specific lots of three catheters due to 19 reports
Videos | Balloon Catheter | November 16, 2016
A discussion with Todd Brinton, M.D., about the newly FDA-cleared Shockwave Medical Lithoplasty System, at the Transc
NuCryo Vascular, Next Generation Cryoplasty Inflation Device, PolarCath Balloon Dilatation System

PolarCath Balloon Dilatation System image courtesy of NuCryo Vascular

Technology | Balloon Catheter | March 28, 2016
NuCryo Vascular LLC announced the launch of the Next Generation Cryoplasty Inflation device. The device received U.S....
NuCryo Vascular, FDA clearance, next-gen, PolarCath System, cryoplasty inflation device
Technology | Balloon Catheter | January 12, 2016
NuCryo Vascular LLC announced that they have received U.S. Food and Drug Administration (FDA) 510(k) clearance on the...
Videos | Balloon Catheter | October 30, 2015
Todd Brinton, M.D., clinical associate professor and consulting associate professor of bioengineering at Stanford Uni
Overlay Init